Entamoeba histolytica

Jump to navigation Jump to search

Amoebiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Amoebiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Imaging

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Entamoeba histolytica On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Entamoeba histolytica

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Entamoeba histolytica

CDC onEntamoeba histolytica

Entamoeba histolytica in the news

Blogs on Entamoeba histolytica

to Hospitals Treating Amoebiasis

Risk calculators and risk factors for Entamoeba histolytica

style="background:#Template:Taxobox colour;"|Entamoeba histolytica
Entamoeba histolytica cyst
Entamoeba histolytica cyst
style="background:#Template:Taxobox colour;" | Scientific classification
Domain: Eukaryota
Phylum: Amoebozoa
Class: Archamoebae
Genus: Entamoeba
Species: E. histolytica
Error creating thumbnail: File missing
Life-cycle of the Entamoeba histolytica
This page is about microbiologic aspects of the organism(s).  For clinical aspects of the disease, see Amoebiasis.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]

Overview

Higher Order Classification

Cellular organisms; Eukaryota; Protista; Amoebozoa; Archamoebae; Entamoeba

Natural Reservoir

  • Usually humans (only)
  • Reports of animals as natural reservoirs of E. histolytica have been described.

Microbiological Characteristics

Genus and Species Entamoeba histolytica
Etiologic Agent of: Amoebiasis; Amoebic dysentery; Extraintestinal Amoebiasis, usually Amoebic Liver Abscess = “anchovy sauce”); Amoeba Cutis; Amoebic Lung Abscess (“liver-colored sputum”)
Infective stage Cyst
Definitive Host Human
Portal of Entry Mouth
Mode of Transmission Ingestion of mature cyst through contaminated food or water
Habitat Colon and Cecum
Pathogenic Stage Trophozoite
Locomotive apparatus Pseudopodia (“False Foot”)
Motility Active, Progressive and Directional
Nucleus 'Ring and dot' appearance: peripheral chromatin and central karyosome
Mode of Reproduction Binary Fission
Pathogenesis Lytic necrosis (it looks like “flask-shaped” holes in Gastrointestinal tract sections (GIT)
Type of Encystment Protective and Reproductive
Lab Diagnosis Most common is Direct Fecal Smear (DFS) and staining (but does not allow identification to species level); Enzyme immunoassay (EIA); Indirect Hemagglutination (IHA); Antigen detection – monoclonal antibody; PCR for species identification. Culture: From faecal samples - Robinson's medium, Jones' medium
Treatment Metronidazole for the invasive trophozoites PLUS a luminal amoebicide for those still in the intestine (Paromomycin is the most widely used)
Trophozoite Stage
Pathognomonic/Diagnostic Feature Ingested RBC; distinctive nucleus
Cyst Stage
Chromatoidal Body 'Cigar' shaped bodies (made up of crystalline ribosomes)
Number of Nuclei 1 in early stages, 4 when mature
Pathognomonic/Diagnostic Feature 'Ring and dot' nucleus and chromatoid bodies

Genome

Life Cycle

[Image:Amebiasis_LifeCycle.gif] Retrieved from the Centers for Disease Control and Prevention

  • Cysts and trophozoites are passed in human feces. Cysts are typically found in formed stool, whereas trophozoites are typically found in diarrheal stool.
  • Infection by Entamoeba histolytica occurs by ingestion of mature cysts in fecally contaminated food, water, or hands.
  • Excystation occurs in the small intestine and trophozoites are released, which migrate to the large intestine.
  • The trophozoites multiply by binary fission and produce cysts, and both stages are passed in the feces.
  • Because of the protection conferred by their walls, the cysts can survive days to weeks in the external environment and are responsible for transmission.
  • Trophozoites passed in the stool are rapidly destroyed once outside the body, and if ingested would not survive exposure to the gastric environment.
  • In many cases, the trophozoites remain confined to the intestinal lumen (A: noninvasive infection) of individuals who are asymptomatic carriers, passing cysts in their stool.
  • In some patients the trophozoites invade the intestinal mucosa (B: intestinal disease), or, through the bloodstream, extraintestinal sites such as the liver, brain, and lungs (C: extraintestinal disease), with resultant pathologic manifestations.
  • It has been established that the invasive and noninvasive forms represent two separate species, respectively E. histolytica and E. dispar. These two species are morphologically indistinguishable unless E. histolytica is observed with ingested red blood cells (erythrophagocystosis).
  • Transmission can also occur through exposure to fecal matter during sexual contact (in which case not only cysts, but also trophozoites could prove infective).


Gallery

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 "Public Health Image Library (PHIL)".


Template:WikiDoc Sources